Genomic characterisation and risk stratification of AML
26 Sep 2016
Genomic characterisation and risk stratification of AML
Screening Patients for Efficient Clinical Trial Access (SPECTA)
IBCD 2016: Integrating assays into clinical trials
Innovative imaging techinques to visualise drug targets
Design and value of immunohistochemical assays
Oncolytic virotherapy in the treatment of melanoma
What is the role of surgery in melanoma treatment?
Risk factors for childhood cancer: what are the challenges in research?
Genetic polymorphisms associated with childhood AML
The role of chemotherapy for metastatic melanoma
Making sense of genetic associations with childhood leukaemia risk
Childhood Cancer 2016: The potential of immunotherapy